{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "19405401", "DateCompleted": {"Year": "2009", "Month": "07", "Day": "14"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "18"}, "Article": {"Language": ["ukr"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0023-2130", "JournalIssue": {"Issue": "10", "PubDate": {"Year": "2008", "Month": "Oct"}}, "Title": "Klinichna khirurhiia", "ISOAbbreviation": "Klin Khir"}, "ArticleTitle": "[Application of ozone therapy in complex treatment of patients with acute necrotizing pancreatitis].", "Pagination": {"StartPage": "28", "EndPage": "31", "MedlinePgn": "28-31"}, "Abstract": {"AbstractText": ["Examination and treatment of 32 patients was done, in whom an acute necrotic pancreatitis was diagnosed. In 16 patients (the main group) ozonotherapy, according to scheme, elaborated in the clinic, was added to conventional treatment. The ozonotherapy application had permitted to reduce the rate of performance of \"open\" operative interventions. The cellular, humoral and local immunity improvement and biochemical indices normalization were noted. The stationary treatment duration was 21.4 days at average in the main group and 34.5 -- in a control one. The relaparotomy performance rate in the main group was lesser than in a control one."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Kopchak", "ForeName": "V M", "Initials": "VM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khomiak", "ForeName": "I V", "Initials": "IV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Duvalko", "ForeName": "A V", "Initials": "AV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Stasenko", "ForeName": "A A", "Initials": "AA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dieiev", "ForeName": "V A", "Initials": "VA"}], "PublicationTypeList": ["Clinical Trial", "English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Ukraine", "MedlineTA": "Klin Khir", "NlmUniqueID": "9516872", "ISSNLinking": "0023-2130"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin A"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin G"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin M"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["drug effects"], "DescriptorName": "Antibody Formation"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Immunity, Cellular"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin A"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin G"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin M"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug therapy", "immunology", "surgery", "therapy"], "DescriptorName": "Pancreatitis, Acute Necrotizing"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "5", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "5", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "7", "Day": "15", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19405401"]}}], "PubmedBookArticle": []}